Fungal Infections in Hematology-Oncology Patients Clinical Guide

This document discusses fungal infections in hematology-oncology patients. It covers the epidemiology, diagnosis, and treatment of fungal infections.


Fungal Infections in Hematology-Oncology Patients Clinical Guide - cover page
Category
Health Care
Document type
Other
Language
TR
Pages
67
File format
PDF
File size
5 MB
Published
17 November, 2023
Updated
17 November, 2023
MD5 checksum
00413927035DEEA818463A986C100509

About this manual

This document is a clinical presentation or guide focusing on invasive fungal infections (IFI) in patients with hematological malignancies and oncology. It covers the significance of these infections, including mortality rates and epidemiological data from studies like SEIFEM. The text details specific types of infections such as invasive candidiasis, aspergillosis, and mucormycosis, along with their clinical manifestations in various organs like the skin, lungs, and central nervous system. This manual is written in Turkish.

What's inside

  • Epidemiology of Invasive Fungal Infections
  • Clinical Signs and Symptoms
  • Diagnosis and Laboratory Tests
  • Antifungal Treatment Guidelines
  • Drug Interactions with Immunosuppressants
  • Mortality and Prognosis

Frequently asked questions

What is the mortality rate of invasive fungal infections in adults?

The mortality rate in adults is between 15% and 35%.

Which fungal infection is the most common in hematological malignancies?

Candidosis is the most common, accounting for 55% of cases.

What is the recommended duration of neutropenia for prophylaxis payment exclusion?

Prophylaxis is not covered for patients expected to have neutropenia for 10 days or longer.

Download PDF (5 MB)

Also Manuals